Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-11-19
2011-11-22
Joike, Michele K (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C530S387100, C536S023530
Reexamination Certificate
active
08062886
ABSTRACT:
The present invention provides a plasmid system which facilitates the construction of a single amplifiable plasmid that, having the potential to accommodate many independent expression cassettes, has the ability to express multi-subunit complex proteins such as antibodies and receptors.
REFERENCES:
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: 5198340 (1993-03-01), Mukku
patent: 5262308 (1993-11-01), Baserga
patent: 5942412 (1999-08-01), Prager et al.
patent: 5958872 (1999-09-01), O'Connor et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 6022711 (2000-02-01), Cunningham et al.
patent: 6084085 (2000-07-01), Baserga et al.
patent: 6294330 (2001-09-01), Michnick et al.
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 6316462 (2001-11-01), Bishop et al.
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6346390 (2002-02-01), Olsson et al.
patent: 6372250 (2002-04-01), Pardridge
patent: 6537988 (2003-03-01), Lee
patent: 6645775 (2003-11-01), Clark et al.
patent: 7217796 (2007-05-01), Wang et al.
patent: 2002/0022023 (2002-02-01), Ullrich et al.
patent: 2002/0025313 (2002-02-01), Micklus et al.
patent: 2002/0107187 (2002-08-01), Kingston et al.
patent: 2002/0132275 (2002-09-01), Fidler et al.
patent: 2002/0155095 (2002-10-01), Nagabhushan et al.
patent: 2002/0164333 (2002-11-01), Nemerow et al.
patent: 2002/0169116 (2002-11-01), Kingston et al.
patent: 2002/0187925 (2002-12-01), Kingston et al.
patent: 2002/0197262 (2002-12-01), Hasan et al.
patent: 2003/0021780 (2003-01-01), Smith et al.
patent: 2003/0031658 (2003-02-01), Brodt et al.
patent: 2003/0045676 (2003-03-01), Kingston et al.
patent: 2003/0087342 (2003-05-01), Mermod et al.
patent: 2003/0088061 (2003-05-01), Staunton
patent: 2003/0092631 (2003-05-01), Deshayes et al.
patent: 2003/0138430 (2003-07-01), Stimmel et al.
patent: 2003/0165502 (2003-09-01), Fujita-Yamaguchi
patent: 2003/0195147 (2003-10-01), Pillutla et al.
patent: 2003/0235582 (2003-12-01), Singh et al.
patent: 2003/0236190 (2003-12-01), Pillutla et al.
patent: 2004/0009154 (2004-01-01), Khan et al.
patent: 2004/0009906 (2004-01-01), Kakkis et al.
patent: 2004/0018191 (2004-01-01), Wang et al.
patent: 2004/0023887 (2004-02-01), Pillutla et al.
patent: 2004/0047835 (2004-03-01), Bianco
patent: 2004/0057950 (2004-03-01), Waksal et al.
patent: 2004/0086511 (2004-05-01), Zack et al.
patent: 2004/0102360 (2004-05-01), Barnett et al.
patent: 2004/0116330 (2004-06-01), Naito et al.
patent: 2004/0142381 (2004-07-01), Hubbard et al.
patent: 2004/0228859 (2004-11-01), Graus et al.
patent: 2004/0265307 (2004-12-01), Singh et al.
patent: 2005/0008642 (2005-01-01), Graus et al.
patent: 2005/0048050 (2005-03-01), Fujita-Yamaguchi
patent: 2005/0069539 (2005-03-01), Cohen et al.
patent: 2005/0084906 (2005-04-01), Goetsch et al.
patent: 2005/0186203 (2005-08-01), Singh et al.
patent: 2005/0244408 (2005-11-01), Cohen et al.
patent: 2005/0249728 (2005-11-01), Singh et al.
patent: 2005/0249730 (2005-11-01), Goetsch et al.
patent: 2005/0272637 (2005-12-01), Clinton et al.
patent: 2005/0272755 (2005-12-01), Denis et al.
patent: 2005/0281812 (2005-12-01), Cohen et al.
patent: 2006/0018910 (2006-01-01), Gualberto et al.
patent: 2007/0071675 (2007-03-01), Wu et al.
patent: 2 834 900 (2003-07-01), None
patent: 2 834 990 (2003-07-01), None
patent: 2 834 991 (2003-07-01), None
patent: WO 91/04014 (1991-04-01), None
patent: WO 91/13160 (1991-09-01), None
patent: WO 91/14438 (1991-10-01), None
patent: WO 97/44352 (1997-11-01), None
patent: WO98/17801 (1998-04-01), None
patent: WO 98/22092 (1998-05-01), None
patent: WO 98/45427 (1998-10-01), None
patent: WO 99/25378 (1999-05-01), None
patent: WO 99/28347 (1999-06-01), None
patent: WO 99/42127 (1999-08-01), None
patent: WO 99/60023 (1999-11-01), None
patent: WO 00/22130 (2000-04-01), None
patent: WO 00/50067 (2000-08-01), None
patent: WO 00/69454 (2000-11-01), None
patent: WO 01/07084 (2001-02-01), None
patent: WO 01/30964 (2001-05-01), None
patent: WO 01/36632 (2001-05-01), None
patent: WO 01/70268 (2001-09-01), None
patent: WO 01/70930 (2001-09-01), None
patent: WO 01/72771 (2001-10-01), None
patent: WO 01/75064 (2001-10-01), None
patent: WO 01/88121 (2001-11-01), None
patent: WO 02/04522 (2002-01-01), None
patent: WO 02/07783 (2002-01-01), None
patent: WO 02/14525 (2002-02-01), None
patent: WO 02/27017 (2002-04-01), None
patent: WO 02/31500 (2002-04-01), None
patent: WO 02/43758 (2002-06-01), None
patent: WO 02/053596 (2002-07-01), None
patent: WO 02/054066 (2002-07-01), None
patent: WO 02/072780 (2002-09-01), None
patent: WO 2004/087756 (2002-10-01), None
patent: WO 02/088752 (2002-11-01), None
patent: WO 02/092599 (2002-11-01), None
patent: WO 02/102854 (2002-12-01), None
patent: WO 02/102972 (2002-12-01), None
patent: WO 02/102973 (2002-12-01), None
patent: WO 03/000928 (2003-01-01), None
patent: WO 03/014696 (2003-02-01), None
patent: WO 03/027246 (2003-04-01), None
patent: WO 03/039538 (2003-05-01), None
patent: WO 03/059951 (2003-07-01), None
patent: WO 03/088910 (2003-10-01), None
patent: WO 03/100008 (2003-12-01), None
patent: WO 03/100059 (2003-12-01), None
patent: WO 03/106621 (2003-12-01), None
patent: WO 2004/030625 (2004-04-01), None
patent: WO 2004/030627 (2004-04-01), None
patent: WO 2004/056865 (2004-07-01), None
patent: WO 2004/071529 (2004-08-01), None
patent: WO 2004/083248 (2004-09-01), None
patent: WO 2004/096224 (2004-11-01), None
patent: WO 2004/096224 (2004-11-01), None
patent: WO 2005/005635 (2005-01-01), None
patent: WO 2005/016967 (2005-02-01), None
patent: WO 2005/016970 (2005-02-01), None
patent: WO2005/052005 (2005-06-01), None
patent: WO 2005/061541 (2005-07-01), None
patent: WO 2005/117980 (2005-12-01), None
patent: WO 2006/013472 (2006-02-01), None
patent: WO 2006/020258 (2006-02-01), None
patent: WO2007/093008 (2007-08-01), None
Stefania Benini et al., Inhibition of Insulin-like Growth Factor I Receptor Increases the Antitumor Activity of Doxorubicin and Vincristine Against Ewing's Sarcoma Cells, Clinical Cancer Research, vol. 7, 1790-1797, Jun. 2001.
V.M. Macaulay, Insulin-like Growth Factors and Cancer, Br. J. Cancer, 65, 311-320, 1992.
Mariana Resnicoff et al., The Role of the Insulin-like Growth Factor I Receptor in Transformation and Apoptosis, Kimmel Cancer Institute, Thomas Jefferson University pp. 76-81.
Xiangdang Liu et al., Inhibition of Insulin-like Growth Factor I Receptor Expression in Neuroblastoma Cells Induces the Regression of Established Tumors in Mice, Cancer Research 58, 5432-5438, Dec. 1, 1998.
Jamie L. Resnik et al., Elevated Insulin-like Growth Factor I Receptor Autophosphorylation and Kinase Activity in Human Breast Cancer, Cancer Research 58, 1159-1164, Mar. 15, 1998.
Fredrika Pekonen et al., Receptors for Epidermal Growth Factor and Insulin-like Growth Factor I and Their Relation to Steroid Receptors in Human Breast Cancer, Cancer Research 48, 1343-1347, Mar. 1, 1988.
Quynh T. Rohlik et al., An Antibody to the Receptor for Insulin-like Growth Factor I Inhibits the Growth of MCF-7 Cells in Tissue Culture, Biochemical and Biophysical Research Communications, vol. 149, No. 1, 276-281, 1987.
Carlos L. Arteaga et al., Blockade of the Type I Somatomedin Receptor Inhibits Growth of Human Breast Cancer Cells in Athymic Mice, J. Clin. Invest., vol. 84, 1418-1423, Nov. 1989.
Ted Gansler et al., Rapid Communication Antibody to Type I Insulinlike Growth Factor Receptor Inhibits Growth of Wilms' Tumor in Culture and in Athymic Mice, American Journal of Pathology, vol. 135, No. 6, 961-966, Dec. 1989.
Krzysztof Reiss et al., Inhibition of Tumor Growth by a Dominant Negative Mutant of the Insulin-like Growth Factor I Receptor with a Bystander Effect, Clinical Cancer Research, vol. 4, 2647-2655, Nov. 1998.
Carlos L. Arteaga et al., Growth Inhibition of Human Breast Cancer Cells in Vitro with an Antibody Against the Type I Somatomedin Receptor, Cancer Research, 49, 6237-6241, Nov. 15, 1989.
Sandra E. Dunn et al., A Dominant Negative Mutant of the Insulin-like Growth Factor-I Receptor Inhibits the Adhesion, Invasion, and Metastasis of Breast Cancer, Cancer Research, 58,
Joike Michele K
Schering Corporation
LandOfFree
Plasmid system for multigene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasmid system for multigene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmid system for multigene expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282310